Your browser doesn't support javascript.
loading
Phase II Single-Arm Study of Palbociclib and Cetuximab Rechallenge in Patients with KRAS/NRAS/BRAF Wild-Type Colorectal Cancer.
Sorah, Jonathan D; Moore, Dominic T; Reilley, Matthew J; Salem, Mohamed E; Triglianos, Tammy; Sanoff, Hanna K; McRee, Autumn J; Lee, Michael S.
Afiliação
  • Sorah JD; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Moore DT; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Reilley MJ; Division of Hematology/Oncology, Department of Medicine, University of Virginia, Charlottesville, VA, USA.
  • Salem ME; Levine Cancer Institute, Charlotte, NC, USA.
  • Triglianos T; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Sanoff HK; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • McRee AJ; The Janssen Pharmaceutical Companies of Johnson & Johnson, Raritan, NJ, USA.
  • Lee MS; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Oncologist ; 27(12): 1006-e930, 2022 12 09.
Article em En | MEDLINE | ID: mdl-36288238
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais Idioma: En Ano de publicação: 2022 Tipo de documento: Article